<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335109">
  <stage>Registered</stage>
  <submitdate>29/01/2010</submitdate>
  <approvaldate>24/03/2010</approvaldate>
  <actrnumber>ACTRN12610000249055</actrnumber>
  <trial_identification>
    <studytitle>A Randomised Control Trial of a Group Based Intervention and Relapse Prevention Package for Substance Misuse and Psychosis.</studytitle>
    <scientifictitle>A randomised control trial of a group based intervention and relapse prevention package for substance misuse and psychosis.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Psychosis</healthcondition>
    <healthcondition>Substance Use</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Psychosis and personality disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The intervention consists of an 8 session intergated program for those with co-occurring psychosis and substance use.  It is delevered in a group format for two hours over 8 weeks by qualified and trained mental health professionals.</interventions>
    <comparator>Control consisted of treatment as usual, which is case management through area community mental health services.</comparator>
    <control>Active</control>
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Decreased substance dependence.  The Opiate Treatment Index, the Alcohol Use Disorders Identification test (AUDIT), the Drug Abuse Screening Test (DAST), and the Severity of Substance Use are administered to all participants accross all time points.</outcome>
      <timepoint>3, 6, 9, 12 months and 5 years post intervention</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Decreased impact of psychopathology.  The World health organisation Quality of Life Questionnaire, the Life Skills profile, the Global Assessment of Functioning and the Brief Psychiatric Rating Scale are used for all participants.</outcome>
      <timepoint>3, 6, 9, 12 months and 5 years post intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Increased community service utilisation.  the Diagnostic Interview for Psychosis: Service Utilisation (DIP-Part 3) is administered to all participants.</outcome>
      <timepoint>3, 6, 9, 12 months and 5 years post intervention</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Current Diagnosistic and Statistical Manual, Fourth Edition Revised (DSM-IV) diagnosis of schizophrenia or affective psychosis
Concurrent DSM-IV diagnosis of problematic substance use or dependence
Age 18yrs or over
Able to converse in English without an interpreter
Ability to engage in a one and a half hour group, with a mid-group break.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Age under 16 years
Unable to converse in English without an interpreter
Presence of developmental disability or amnestic syndrome that would impair ability to learn from the intervention.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subject provide informed consent, are assessed at baseline, by a trained research clinician.  Participants are then randomly assigned to control or treatment, by an independant person (statistician), through a central computer randomisation, using block simultaneous randomisation stratified by site, upon sufficient numbers at each site for group to be formed.</concealment>
    <sequence>Computer generated random number sequences, from www.randomization.com.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/01/2003</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>120</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>3021</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other Collaborative groups</primarysponsortype>
    <primarysponsorname>Frameworks For health</primarysponsorname>
    <primarysponsoraddress>Frameworks For Health
55 Victoria Parade Fitzroy, 
Victoria 3065</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>National Health and Medical Research Council (NH&amp;MRC)</fundingname>
      <fundingaddress>National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>St. Vincent's Health Melbourne</sponsorname>
      <sponsoraddress>55 Victoria Parade Fitzroy, 
Victoria 3065</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>University</othercollaboratortype>
      <othercollaboratorname>Swinburne University Of technology</othercollaboratorname>
      <othercollaboratoraddress>PO Box 218
HAWTHORN VIC 3122</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will examine the effectiveness of a brief group-based intervention for those with co-occurring mental illness and substance use disorders.  It is hypothesised that those who receive the intervention will experience less severity of dependance of substances and decreased impact of psychiatric disorder.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>St.Vincent's Health Melbourne HREC-A</ethicname>
      <ethicaddress />
      <ethicapprovaldate>21/10/2002</ethicapprovaldate>
      <hrec>1/02/0114</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Northwestern mental health</ethicname>
      <ethicaddress />
      <ethicapprovaldate>25/10/2002</ethicapprovaldate>
      <hrec>E/02/038</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ben Williams</name>
      <address>Swinburne University of Technology
PO Box 218
HAWTHORN VIC 3122</address>
      <phone>+61 3 9214 8059</phone>
      <fax />
      <email>BWilliams@groupwise.swin.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Brendan Pawsey</name>
      <address>Level, 8 Aikenhead Building
55 Victoria Parade Fitzroy
Victoria 3065</address>
      <phone>+61 39 2882327</phone>
      <fax />
      <email>brendan.pawsey@svhm.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Brendan Pawsey</name>
      <address>Level, 8 Aikenhead Building
55 Victoria Parade Fitzroy
3065 Victoria</address>
      <phone>+61 3 92882327</phone>
      <fax>+61 3 92882360</fax>
      <email>brendan.pawsey@svhm.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>